Mainz Biomed N.V. Ratios

Ratios Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin -21.77%24.94%30.77%34.38%56.91%64.31%
EBT Margin -340.11%-118.91%-2,024.79%-4,979.90%-2,936.50%-2,421.80%
EBIT Margin -327.62%-136.50%-1,684.36%-4,990.60%-2,975.47%-2,091.23%
EBITDA Margin -327.62%-136.50%-1,684.36%-4,990.60%2,992.84%2,433.49%
Operating Margin -327.62%-136.50%-1,684.36%-4,990.60%-2,975.47%-2,091.23%
Net Margin -340.11%-118.91%-2,024.79%-4,979.90%-2,941.94%-2,421.80%
FCF Margin -148.01%-96.93%-560.67%-2,911.63%-2,583.83%-1,923.39%
Efficiency
Inventory Average 0.39M0.49M
Assets Average 5.36M15.14M17.83M14.32M
Equity Average -2.35M1.81M10.23M8.67M4.65M
Invested Capital -1.95M-2.68M6.44M14.17M8.11M8.21M
Asset Utilization Ratio 0.110.030.050.06
Leverage & Solvency
Interest Coverage Ratio -5.88-3.82-28.67-109.26-51.00-17.84
Debt to Equity -0.010.210.071.500.17
Debt Ratio 0.040.130.050.320.08
Equity Ratio -4.070.630.700.210.46
Times Interest Earned -5.88-3.82-28.67-109.26-51.00-17.84
Valuation
Enterprise Value -0.20M-0.12M112.94M85.69M12.36M-2.33M
Market Capitalization 121.67M102.83M19.43M2.76M
Return Ratios
Return on Sales -3.40%-1.19%-20.25%-49.80%-29.36%-24.22%
Return on Capital Employed -2.43%-2.43%-3.10%-2.23%
Return on Assets -2.18%-1.74%-1.48%-1.51%
Return on Equity 0.25%-6.46%-2.58%-3.03%-4.66%